Molejon, M. I., Tellechea, J. I., Loncle, C., Gayet, O., Gilabert, M., Duconseil, P., . . . Iovanna, J. (2015). Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma. Oncotarget.
Dyfyniad Arddull ChicagoMolejon, Maria Inés, et al. "Deciphering the Cellular Source of Tumor Relapse Identifies CD44 As a Major Therapeutic Target in Pancreatic Adenocarcinoma." Oncotarget 2015.
Dyfyniad MLAMolejon, Maria Inés, et al. "Deciphering the Cellular Source of Tumor Relapse Identifies CD44 As a Major Therapeutic Target in Pancreatic Adenocarcinoma." Oncotarget 2015.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.